Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT05683184

PHASE1

OMAR Opioid Use Disorder

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.

Official title: Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

Start Date

2023-03-10

Completion Date

2026-12-15

Last Updated

2025-12-23

Healthy Volunteers

Yes

Conditions

Healthy Control Opioid Use Disorder

Interventions

DRUG

[11C]OMAR

For each \[11C\]OMAR PET scan, up to 20 mCi of \[11C\]OMAR will be administered.

Locations (1)

Connecticut Mental Health Center, Clinical Neuroscience Research Unit

New Haven, Connecticut, United States